Engineered B Cells
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT06611436
BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 4, 2024
Completion: Jul 31, 2027
Loading map...